Read more

October 08, 2021
1 min listen
Save

Top news this week: Systemic corticosteroids linked with worse COVID-19 outcomes

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

This week, use of systemic corticosteroids is linked with worse COVID-19 outcomes; an investigational antiviral drug reduces risk for hospitalization and death by about 50% in patients with COVID-19; Pfizer-BioNTech submit vaccine data for children aged 5 to 11 to FDA; and more.

Read the full coverage here:

Use of systemic corticosteroids linked with worse COVID-19 outcomes

Antiviral reduces risk for hospitalization, death by about 50% in patients with COVID-19

Pfizer-BioNTech submit vaccine data for children aged 5 to 11 to FDA

Unlike flu, cold viruses persisted during pandemic, study finds

AstraZeneca COVID-19 vaccine 74% effective, protects against asymptomatic disease

References:

Yochai A, et al. Asthma treatment: clinical and translational science. Presented at: European Respiratory Society International Congress; Sept. 5-8, 2021 (virtual meeting).

Press Release

Press Release

Rankin, DA, et al. Abstract 154. Presented at: IDWeek; Sept. 29-Oct. 3, 2021 (virtual meeting).

Sobieszczyk M, et al. Abstract LB6. Presented at: IDWeek; Sept. 29-Oct. 3, 2021 (virtual meeting).

Sources/Disclosures

Collapse

Disclosures: Please see each study for relevant financial disclosures.